5 results
6-K
EX-99.2
IFRX
InflaRx N.V.
10 Jan 22
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
7:30am
extension (OLE): in the responder group, 71% maintain HiSCR response by week 40; signals of sustainable reduction of lesion counts during long term
6-K
EX-99.1
IFRX
InflaRx N.V.
30 Jun 20
Current report (foreign)
6:38am
with the qualities, skills and experience needed to support and promote the growth and sustainable success of the Company and its business, even during
424B4
IFRX
InflaRx N.V.
7 May 18
Prospectus supplement with pricing info
4:47pm
trading market for our common shares may not be sustainable. If an active trading market is not maintained, investors may not be able to resell
F-1
IFRX
InflaRx N.V.
2 May 18
Registration statement (foreign)
7:10am
as a public company
An active trading market for our common shares may not be sustainable. If an active trading market is not maintained, investors may
- Prev
- 1
- Next